Nisa Investment Advisors
TGTX icon

Nisa Investment Advisors’s TG Therapeutics TGTX Stock Holding History

Nisa Investment Advisors’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$486K Buy
8,854
+1,229
+16% +$50.3K ﹤0.01% 983
2026
Q1 		$253K Buy
7,625
+310
+4% +$9.24K ﹤0.01% 1132
2025
Q4 		$218K Sell
7,315
-140
-2% -$4.57K ﹤0.01% 1216
2025
Q3 		$269K Sell
7,455
-6,830
-48% -$225K ﹤0.01% 1178
2025
Q2 		$514K Buy
14,285
+6,200
+77% +$231K ﹤0.01% 992
2025
Q1 		$319K Sell
8,085
-27
-0.3% -$908 ﹤0.01% 1115
2024
Q4 		$244K Buy
8,112
+2,803
+53% +$80.4K ﹤0.01% 1235
2024
Q3 		$124K Sell
5,309
-110
-2% -$2.4K ﹤0.01% 1389
2024
Q2 		$96.4K Buy
5,419
+103
+2% +$1.64K ﹤0.01% 1486
2024
Q1 		$80.9K Buy
5,316
+136
+3% +$2.17K ﹤0.01% 1533
2023
Q4 		$88.5K Sell
5,180
-45,100
-90% -$524K ﹤0.01% 1470
2023
Q3 		$420K Sell
50,280
-35,800
-42% -$499K ﹤0.01% 1113
2023
Q2 		$2.14M Sell
86,080
-20,200
-19% -$522K 0.02% 658
2023
Q1 		$1.6M Buy
106,280
+30,760
+41% +$467K 0.01% 721
2022
Q4 		$893K Buy
75,520
+65,300
+639% +$474K 0.01% 942
2022
Q3 		$59K Buy
10,220
+8,969
+717% +$58.8K ﹤0.01% 1686
2022
Q2 		$5K Sell
1,251
-74,400
-98% -$465K ﹤0.01% 2274
2022
Q1 		$719K Buy
75,651
+56,900
+303% +$659K 0.01% 969
2021
Q4 		$217K Sell
18,751
-7,966
-30% -$207K ﹤0.01% 1244
2021
Q3 		$889K Buy
26,717
+62
+0.2% +$1.92K 0.01% 951
2021
Q2 		$1.03M Buy
26,655
+300
+1% +$11.8K 0.01% 927
2021
Q1 		$1.27M Sell
26,355
-215
-0.8% -$10.3K 0.01% 867
2020
Q4 		$1.38M Buy
26,570
+5,520
+26% +$186K 0.01% 803
2020
Q3 		$563K Buy
21,050
+2,700
+15% +$62.1K ﹤0.01% 1010
2020
Q2 		$357K Hold
18,350
– – ﹤0.01% 1138
2020
Q1 		$181K Sell
18,350
-75
-0.4% -$947 ﹤0.01% 1217
2019
Q4 		$205K Hold
18,425
– – ﹤0.01% 1320
2019
Q3 		$103K Hold
18,425
– – ﹤0.01% 1453
2019
Q2 		$159K Hold
18,425
– – ﹤0.01% 1356
2019
Q1 		$148K Hold
18,425
– – ﹤0.01% 1363
2018
Q4 		$76K Buy
18,425
+17,500
+1,892% +$87K ﹤0.01% 1403
2018
Q3 		$5K Hold
925
– – ﹤0.01% 1873
2018
Q2 		$12K Buy
925
+400
+76% +$5.5K ﹤0.01% 1681
2018
Q1 		$7K Sell
525
-675
-56% -$8.63K ﹤0.01% 1742
2017
Q4 		$10K Buy
1,200
+200
+20% +$1.75K ﹤0.01% 1742
2017
Q3 		$12K Hold
1,000
– – ﹤0.01% 1701
2017
Q2 		$10K Buy
1,000
+400
+67% +$4.48K ﹤0.01% 1723
2017
Q1 		$7K Buy
+600
New +$4.31K ﹤0.01% 1765

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Nisa Investment Advisors's TGTX Position: Q2 2026 in Review

Nisa Investment Advisors increased its TG Therapeutics (TGTX) stake by 16% in Q2 2026, buying an estimated $50.3K and bringing the position to 8,854 shares worth $486K. The position accounts for ﹤0.01% of the portfolio, ranked #983.

Nisa Investment Advisors first reported a position in TGTX in Q1 2017 and has held it in 38 quarters since. The position peaked at $2.14M in Q2 2023. 430 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Nisa Investment Advisors held 8,854 shares of TG Therapeutics worth $486K as of Q2 2026.
  • Nisa Investment Advisors bought 1,229 TG Therapeutics shares in Q2 2026, an estimated $50.3K.
  • TG Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #983 holding.
  • Nisa Investment Advisors first reported a position in TG Therapeutics in Q1 2017 and has held it in 38 quarters since.
  • Nisa Investment Advisors's TG Therapeutics position peaked at $2.14M in Q2 2023.
  • 430 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.